In endometrioid carcinomas, ARID1A mutations often co-occurred with PTEN mutations, and concurrent loss of those tumor suppressors has been shown to have synergistic effects on tumorigenesis [77]. This evidence concerns the gene ARID1A and endometrioid adenocarcinoma.